Ascendis Pharma A/S - Special Call Transcript
/- -
Okay. We're going to get started. Thanks, everyone for joining us. I'm Scott Smith, Chief Financial Officer of Ascendis.
As you might have expected, we'll be making some forward-looking statements. Please refer to our SEC filings for the associated risk factors. And here's the agenda. So first of all, I'd like to say welcome to everyone. Thanks for coming. Thanks for giving us the opportunity to present to you, the investment community, Ascendis Pharma, our current pipelines and future pipeline.
We have an action-packed agenda today. And as a lot of you know, we have a very strong German contingent at Ascendis. So we'll try to stay right on time. So we'll stick as closely as we can to the schedule. From a housekeeping item perspective, if you can just make sure to mute your cell phones. That would be appreciated.
And I think with that, I will turn it over to Jan to give a more detailed introduction.
¸
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |